December 8, 2024
Intangible Assets

Samsung Takes Jab At Bayer, Regeneron Eye Patents


By Hanna Vioque (August 15, 2024, 7:22 PM BST) — Samsung’s pharmaceutical unit wants a London judge to nix two patents owned by its rivals that help treat eye disorders, arguing that they are both invalid as it prepares to launch a biosimilar….

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *